Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study

Exclusion Criteria

• •Implantable electronic devices (i.e., automatic defibrillator)
• •Active infection or history of infection in designated test area within 90 days prior to first treatment
• •Not willing or able to sign the Informed Consent
• •Known to be immune-compromised
• •Known to be keloid producer
• •Taking blood thinning medications
• •Insulin dependent, Type I diabetics
• •Allergies to Lidocaine or Lidocaine-like products
• •Employed by the sponsor, clinic site, or entity associated with the conduct of the study
• •Family member of someone employed by the sponsor, clinic site, or entity associated with the conduct of the study
• •Have any condition or situation which, in the Investigator's opinion, puts the subject at significant risk, could confound the study results, or may interfere significantly with the subject's participation in the study
• •Prior inability to complete required study visits during treatment period.
• •Use of any other investigational drug, therapy, or device within the past 30 days of enrollment or concurrent participation in another research study